| 1.23 0.2 (19.42%) | 09-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1.43  |
1-year : | 1.67 |
| Resists | First : | 1.23 |
Second : | 1.43 |
| Pivot price | 0.93 |
|||
| Supports | First : | 0.8 |
Second : | 0.55 |
| MAs | MA(5) : | 1.02 |
MA(20) : | 0.86 |
| MA(100) : | 1.12  |
MA(250) : | 1.94 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 84.7 |
D(3) : | 75.4 |
| RSI | RSI(14): 71 |
|||
| 52-week | High : | 7.5 | Low : | 0.55 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SHOT ] has closed above the upper band by 22.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 9.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.23 - 1.23 | 1.23 - 1.24 |
| Low: | 0.99 - 0.99 | 0.99 - 1 |
| Close: | 1.22 - 1.23 | 1.23 - 1.24 |
Jupiter Wellness, Inc., a wellness company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Sat, 07 Sep 2024
Safety Shot Secures U.S. Patent, Enhances Market Leadership - TipRanks
Fri, 06 Sep 2024
Safety Shot secures patent for rapid BAC reduction formula - Investing.com
Fri, 06 Sep 2024
Safety Shot secures patent for alcohol reduction formula - Investing.com
Fri, 06 Sep 2024
Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims - PR Newswire
Fri, 06 Sep 2024
Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | -12 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 5.202e+007 (%) |
| Held by Institutions | 3.685e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.89 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 184.5 % |
| Return on Equity (ttm) | -189.5 % |
| Qtrly Rev. Growth | 1.03e+006 % |
| Gross Profit (p.s.) | 211.24 |
| Sales Per Share | -277.47 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -3.259e+007 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -1.39 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 0 |
| Dividend | 4.8e+006 |
| Forward Dividend | 4.11e+006 |
| Dividend Yield | 390244000% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|